Role of sphingolipids in oestrogen signalling in breast cancer cells: an update

Olga Sukocheva, Carol Wadham

    Research output: Contribution to journalArticle

    18 Citations (Scopus)

    Abstract

    The signaling pathways activated by the steroid hormone oestrogen include a variety of cytoplasmic second messengers linked to a multitude of tissue-specific effects. In thelast decade, sphingolipids and their membrane receptors were added to the list of oestrogenactivated mediators. Oestrogen triggers the sphingolipid signalling cascade in varioustissues including breast cancer. Extensive research has shown that sphingolipids are thekey regulatory molecules in growth factor networks. Sphingolipids can control the rate of cell proliferation and the differentiation outcome during malignant transformation. In this study, we summarise novel experimental evidences linking sphingolipids to oestrogenactivated effects, highlight the role of sphingolipids in cancer cells and discuss new avenues for future research at the intersection between oestrogen and sphingolipid signalling.

    Original languageEnglish
    Pages (from-to)R25-R35
    Number of pages11
    JournalJournal of Endocrinology
    Volume220
    Issue number3
    DOIs
    Publication statusPublished - 2014

    Fingerprint Dive into the research topics of 'Role of sphingolipids in oestrogen signalling in breast cancer cells: an update'. Together they form a unique fingerprint.

  • Cite this